Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP-3000 (ropinirole patch) in Parkinson's disease patients on L-DOPA
jRCT2080221835Phase 2
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ropinirole in Parkinson's disease (PD) (2 arms), sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080221835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221835.